|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02162 KEYMED BIO-B
Nominal 
41.700 -9.400 (-18.395%) | 2022/12 - Final RMB(¥) | %Chg (Final to Final) | 2021/12 RMB(¥) | 2020/12 RMB(¥) | 2019/12 RMB(¥) | |||
| Turnover | 100,063,000 | -9.256% | 110,269,000 | 0 | 0 | ||
| Cost of Sales | (2,585,000) | -84.971% | (17,200,000) | -- | -- | ||
| Gross Profit | 97,478,000 | 4.737% | 93,069,000 | -- | -- | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | ||
| Change in FV & Impairment on Others | -- | -- | (3,480,294,000) | (696,470,000) | (97,212,000) | ||
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | ||
| Other Non-operating Items | -- | -- | (37,932,000) | (280,000) | -- | ||
| Share of Results of Asso. & JCEs | (9,711,000) | 1250.626% | (719,000) | 0 | 0 | ||
| Profit / (Loss) before Taxation | (303,597,000) | -92.201% | (3,892,632,000) | (818,848,000) | (167,512,000) | ||
| Taxation | 0 | -- | 0 | 0 | 0 | ||
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | ||
| Non-controlling Interests | (4,518,000) | -- | 5,323,000 | 265,000 | 0 | ||
| Others | -- | -- | -- | -- | -- | ||
| Profit / (Loss) Attributable to Shareholders | (308,115,000) | -92.074% | (3,887,309,000) | (818,583,000) | (167,512,000) | ||
| Net Finance Costs / (Income) | (45,919,000) | -- | 4,120,000 | 8,826,000 | 4,560,000 | ||
| Depreciation & Amortisation | 36,123,000 | 71.859% | 21,019,000 | 18,992,000 | 12,299,000 | ||
| Directors' Emoluments | -- | -- | 7,728,000 | 1,171,000 | 918,000 | ||
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | ||
Market Valuation Indicators
| EPS (cts) | -118.000 | -- | -2,417.000 | -1,220.000 | -- | |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | |
| Cash flow per share ($) | -- | -- | -1.334 | -1.779 | -- | |
| NBV per share ($) | 11.941 | -- | 13.052 | -- | -- |
| Remarks: | Real time quote last updated: 29/05/2023 10:40 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -308,115,000 |
| %Change | -92.074% |
| EPS / (LPS) | RMB -1.180 |
| NBV Per Share (¥) | RMB 11.941 |